Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9403839rdf:typepubmed:Citationlld:pubmed
pubmed-article:9403839lifeskim:mentionsumls-concept:C1261468lld:lifeskim
pubmed-article:9403839lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:9403839lifeskim:mentionsumls-concept:C0033681lld:lifeskim
pubmed-article:9403839lifeskim:mentionsumls-concept:C1420192lld:lifeskim
pubmed-article:9403839lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:9403839lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:9403839lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:9403839lifeskim:mentionsumls-concept:C1999230lld:lifeskim
pubmed-article:9403839lifeskim:mentionsumls-concept:C0127400lld:lifeskim
pubmed-article:9403839lifeskim:mentionsumls-concept:C0656325lld:lifeskim
pubmed-article:9403839pubmed:issue2-3lld:pubmed
pubmed-article:9403839pubmed:dateCreated1998-1-15lld:pubmed
pubmed-article:9403839pubmed:abstractTextThe mechanism by which anti-fusion regulatory protein-1 (FRP-1) monoclonal antibody (mAb) induced cell fusion was investigated using U2ME-7 cells that are CD4+U937 cells transfected with the HIV gp160 gene. Protein kinase inhibitors (H-7, H-89, herbimycin A and genistein) suppressed cell fusion of Cd+U2ME-7 cells induced by anti-FRP-1 mAb. H-7 and H-89 also inhibited the cell aggregation, but herbimycin A and genistein did not. Intriguingly, only when herbimycin A was added either before or simultaneously with addition of anti-FRP-1 mAb, was cell fusion suppressed, suggesting that tyrosine kinase is related with the initial step of polykaryocyte formation. Anti-FRP-1 mAb induced the rapid tyrosine phosphorylation of multiple cellular proteins. These effects occurred within 1 min and returned to near baseline by 60 min. The rapid tyrosine phosphorylation was suppressed by herbimycin A and genistein. Although it remains to be determined which protein tyrosine kinase(s) is involved in this response, pp130 tyrosine phosphorylation appears to be a specific and early signal transmitted after the interaction of FRP-1 with a specific antibody. pp130 was present in the cytosol fraction and was distinct from pp125FAK, p130CAS, vinculin, and beta 1-integrin. Thus, our study may present evidence for a novel pathway of protein tyrosine kinases that phosphorylate specific, still unknown protein substrates during polykaryocyte formation.lld:pubmed
pubmed-article:9403839pubmed:languageenglld:pubmed
pubmed-article:9403839pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:citationSubsetIMlld:pubmed
pubmed-article:9403839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9403839pubmed:statusMEDLINElld:pubmed
pubmed-article:9403839pubmed:monthOctlld:pubmed
pubmed-article:9403839pubmed:issn0300-8584lld:pubmed
pubmed-article:9403839pubmed:authorpubmed-author:ItoYYlld:pubmed
pubmed-article:9403839pubmed:authorpubmed-author:WatanabeNNlld:pubmed
pubmed-article:9403839pubmed:authorpubmed-author:SakuraiMMlld:pubmed
pubmed-article:9403839pubmed:authorpubmed-author:OkamotoKKlld:pubmed
pubmed-article:9403839pubmed:authorpubmed-author:KawanoMMlld:pubmed
pubmed-article:9403839pubmed:authorpubmed-author:IdeSSlld:pubmed
pubmed-article:9403839pubmed:authorpubmed-author:NishioMMlld:pubmed
pubmed-article:9403839pubmed:authorpubmed-author:SugaSSlld:pubmed
pubmed-article:9403839pubmed:authorpubmed-author:TabataNNlld:pubmed
pubmed-article:9403839pubmed:authorpubmed-author:KomadaHHlld:pubmed
pubmed-article:9403839pubmed:authorpubmed-author:TsurudomeMMlld:pubmed
pubmed-article:9403839pubmed:authorpubmed-author:OhgimotoSSlld:pubmed
pubmed-article:9403839pubmed:issnTypePrintlld:pubmed
pubmed-article:9403839pubmed:volume186lld:pubmed
pubmed-article:9403839pubmed:ownerNLMlld:pubmed
pubmed-article:9403839pubmed:authorsCompleteYlld:pubmed
pubmed-article:9403839pubmed:pagination115-23lld:pubmed
pubmed-article:9403839pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:meshHeadingpubmed-meshheading:9403839-...lld:pubmed
pubmed-article:9403839pubmed:year1997lld:pubmed
pubmed-article:9403839pubmed:articleTitleProtein tyrosine kinase activation provides an early and obligatory signal in anti-FRP-1/CD98/4F2 monoclonal antibody induced cell fusion mediated by HIV gp160.lld:pubmed
pubmed-article:9403839pubmed:affiliationDepartment of Microbiology, Mie University School of Medicine, Japan.lld:pubmed
pubmed-article:9403839pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9403839pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:6422entrezgene:pubmedpubmed-article:9403839lld:entrezgene
entrez-gene:6520entrezgene:pubmedpubmed-article:9403839lld:entrezgene
entrez-gene:8140entrezgene:pubmedpubmed-article:9403839lld:entrezgene
entrez-gene:155971entrezgene:pubmedpubmed-article:9403839lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:9403839lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:9403839lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:9403839lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:9403839lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:9403839lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:9403839lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9403839lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9403839lld:pubmed